Apolipoprotein E and Alzheimer disease: An update on genetic and functional analyses

Journal of Neuropathology and Experimental Neurology

Volumn 59, Issue 9, 2000, Pages 751-758

  Saunders, Ann M ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Alzheimer disease; Apolipoprotein E; Genetics; Polymorphisms

Indexed keywords

AMYLOID; APOLIPOPROTEIN E; APOLIPOPROTEIN E2; APOLIPOPROTEIN E3; APOLIPOPROTEIN E4; GLUCOSE; MICROTUBULE PROTEIN;

ALZHEIMER DISEASE; ARTICLE; BRAIN PROTECTION; CELL ULTRASTRUCTURE; DNA POLYMORPHISM; GENE LOCUS; GENETIC SUSCEPTIBILITY; GLUCOSE METABOLISM; HUMAN; IMMUNOMODULATION; MICROTUBULE; NEUROPATHOLOGY; NONHUMAN; ONSET AGE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN METABOLISM; PROTEIN STRUCTURE; REMISSION; RISK ASSESSMENT; SIGNAL TRANSDUCTION; STRUCTURE ACTIVITY RELATION;

EID: 0033795279     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1093/jnen/59.9.751     Document Type: Article

References (75)

1. Molecular genetics of Alzheimer's disease
2. Measuring the genetic contribution of APOE in late-onset Alzheimer diease
3. Apolipoprotein E, epsilon 4 allele as a major risk factor for sporadic early and late-onset forms of Alzheimer's disease: Analysis of the 19q13. 2 chromosomal region
4. Apolipoprotein E4 allele in a population-based study of early-onset Alzheimer's disease
5. Apolipoprotein E: Structure-function relationship
6. Phenotypes of apolipoprotein B and apolipoprotein E after liver transplantation
7. Cerebrospinal fluid proteins studied by two-dimensional gel electrophoresis and immunoblotting technique
8. Structures and functions of multiligand lipoprotein receptors: Macrophage scavenger receptors and LDL receptor-related protein (LRP)
9. Specific regional transcription of apolipoprotein E in human brain neurons
10. Nascent astrocyte particles differ from lipoproteins in CSF
11. Apolipoprotein E: High-avidity binding to beta-amyloid and increased frequency of type 4 allele in late-onset familial Alzheimer disease
12. Association of apolipoprotein E allele epsilon 4 with late-onset familial and sporadic Alzheimer's disease
13. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families
14. Protective effect of apolipoprotein E type 2 allele for late onset Alzheimer disease
15. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. APOE and Alzheimer Disease Meta Analysis Consortium
16. Apolipoprotein E, survival in Alzheimer's disease patients, and the competing risks of death and Alzheimer's disease
17. Accelerated decline in apolipoprotein E-epsilon4 homozygotes with Alzheimer's disease
18. ApoE genotype is a risk factor in nonpresenilin early-onset Alzheimer's disease families
19. Alzheimer's disease and possible gene interaction
20. Amyloid angiopathy in a Volga German family with Alzheimer's disease and a presenilin-2 mutation (N14II)
21. Consensus guidelines for the clinical and pathologic diagnosis of dementia with Lewy bodies (DLB): Report of the consortium on DLB international workshop
22. The apolipoprotein E allele epsilon 4 is overrepresented in patients with the Lewy body variant of Alzheimer's disease
23. Alzheimer's disease with and without coexisting Parkinson's disease changes: Apolipoprotein E genotype and neuropathologic correlates
24. Influence of apolipoprotein E genotype on senile dementia of the Alzheimer and Lewy body types. Significance for etiological theories of Alzheimer's disease
25. Apo E genotypes in multiple sclerosis, Parkinson's disease, schwannomas and late-onset Alzheimer's disease
26. Apolipoprotein E genotyping in differential diagnosis, not prediction, of Alzheimer's disease (Point of View)
27. Specificity, sensitivity and predictive value of apolipoprotein E genotyping in a consecutive autopsy series of sporadic Alzheimer disease
28. Apolipoprotein-E genotyping in the diagnosis of Alzheimer's disease in an autopsy confirmed series
29. Apoliprotein E genotypes in a neuropathological series from the Consortium to Establish a Registry for Alzheimer's disease (CERAD)
30. Utility of the apolipoprotein E genotype in the diagnosis of Alzheimer's disease. Alzheimer's Disease Centers Consortium on Apolipoprotein E and Alzheimer's Disease
31. ApoE genotype and survival from intracerebral hemorrhage
32. Apolipoprotein E epsilon4 associated with chronic traumatic brain injury in boxing
33. Synergistic effects of traumatic head injury and apolipoprotein-ε4 in patients with Alzheimer's disease
34. Apolipoprotein E epsilon 4 allele is associated with deposition of amyloid beta-protein following head injury
35. Head injury, amyloid β and Alzheimer's disease
36. ApoE as a prognostic factor for post-traumatic coma
37. Apolipoprotein E allele frequency in patients with cognitive defects following cardiopulmonary bypass
38. Neuronal cytoskeletal changes are an early consequence of repetitive head injury
39. Tau pathology in two Dutch families with mutations in the microtubule-binding region of tau
40. Apolipoprotein E: From atherosclerosis to Alzheimer's disease and beyond
41. Reelin is a ligand for lipoprotein receptors
42. Direct binding of reelin to VLDL receptor and apoE receptor 2 induces tyrosine phosphorylation of disabled-1 and modulates tau phosphorylation
43. Clinical, pathological, and neurochemical changes in dementia: A subgroup with preserved mental status and numerous neocortical plaques
44. Increased amyloid beta-peptide deposition in cerebral cortex as a consequence of apolipoprotein E genotype in late-onset Alzheimer disease
45. Apolipoprotein E allele epsilon 4 is linked to increased deposition of the amyloid beta-peptide (A-beta) in cases with or without Alzheimer's disease
46. Regional variation in the distribution of apolipoprotein E and A beta in Alzheimer's disease
47. Apolipoprotein E genotype and deposits of Abeta40 and Abeta42 in Alzheimer disease
48. A beta-peptide length and apolipoprotein E genotype in Alzheimer's disease
49. Lack of apolipoprotein E dramatically reduces amyloid beta-peptide deposition
50. Expression of human apolipoprotein E reduces amyloid-beta deposition in a mouse model of Alzheimer's disease
51. The interaction between apolipoprotein E and Alzheimer's amyloid beta-peptide is dependent on beta-peptide conformation
52. Binding of human apolipoprotein E to synthetic amyloid beta peptide: Isoformspecific effects and implications for late-onset Alzheimer disease
53. Apolipoprotein E forms stable complexes with recombinant Alzheimer's disease beta-amyloid precursor protein
54. Isoform-specific binding of apolipoprotein E to beta-amyloid
55. Native complex formation between apolipoprotein E isoforms and the Alzheimer's disease peptide A beta
56. Amino-terminus truncated apolipoprotein E is the major species in amyloid deposits in Alzheimer's disease-affected brains: A possible role for apolipoprotein E in Alzheimer's disease
57. Further characterization of a monoclonal antibody recognizing apolipoprotein E peptides in amyloid deposits
58. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease
59. Perspective: On the metabolism of apolipoprotein E and the Alzheimer diseases
60. Isoform-specific interactions of apolipoprotein E with microtubule-associated protein tau: Implications for Alzheimer disease
61. ApoE3 binding to tau tandem repeat I is abolished by tau serine262 phosphorylation
62. Isoform-specific interactions of apolipoprotein E with the microtubule associated protein MAP2c: Implications for Alzheimer's disease
63. Differential binding of apolipoprotein E isoforms to tau and other cytoskeletal proteins
64. The inhibitory effect of apolipoprotein E4 on neurite outgrowth is associated with microtubule depolymerization
65. Human apolipoprotein E accelerates microtubule polymerization in vitro
66. Apolipoprotein E (ApoE) peptide regulates tau phosphorylation via two different signaling pathways
67. Neurodegeneration in the central nervous system of apoE-deficient mice
68. Behavioural, physiological and morphological analysis of a line of apolipoprotein E knockout mouse
69. Phosphorylation of tau in apolipoprotein E-deficient mice
70. Phosphorylation of tau protein is not affected in mice lacking apolipoprotein E
71. Neurodegeneration and cognitive impairment in apoE-deficient mice is ameliorated by infusion of recombinant apoE
72. Severe learning deficits in apolipoprotein E-knockout mice in a water maze task
73. Apolipoprotein-E deficiency results in an altered stress responsiveness in addition to an impaired spatial memory in young mice
74. Apolipoprotein E type 4 allele and cerebral glucose metabolism in relatives at risk for familial Alzheimer disease
75. Preclinical evidence of Alzheimer's disease in persons homozygous for the epsilon 4 allele for apolipoprotein E